Drug intelligence / Profile preview

Creagel EZ 7 + Alphaflow 20 + autologous platelet-rich fibrin

Development stage
Unknown
Lead developer
Poznan University of Medical Sciences
Modality
Cell Therapies
Administration
Topical
01

Overview

This investigational cosmetic formulation, developed by the Poznan University of Medical Sciences, is a topical cream designed to treat skin aging. The product utilizes a base composed of Creagel EZ 7 and Alphaflow 20 (emulsifying and emollient agents) loaded with autologous platelet-rich fibrin (PRF) at a concentration of 2 mL per 100 g of cream. PRF is a second-generation platelet concentrate derived from the patient's own blood, containing a high concentration of platelets, growth factors (such as PDGF, TGF-β, and VEGF), and a fibrin matrix. When applied topically, these components promote tissue regeneration, enhance skin hydration, and improve elasticity by stimulating cellular processes in the dermis and epidermis. Clinical evaluation in healthy volunteers has demonstrated its efficacy in reducing transepidermal water loss (TEWL) and improving overall skin barrier function.

Other names
PRF-loaded creamPRF in Face Care CreamLiquid Fraction of Platelet-rich Fibrin in Face Care Cream

Beyond the preview

Go deeper on Creagel EZ 7 + Alphaflow 20 + autologous platelet-rich fibrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Creagel EZ 7 + Alphaflow 20 + autologous platelet-rich fibrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call